logo
Plus   Neg
Share
Email

Darden Restaurants Initiates Weak FY20 Outlook; Boosts Qtly Dividend 17%

While reporting financial results for the fourth quarter on Thursday, Darden Restaurants, Inc. (DRI) initiated financial outlook for the full-year 2020, with is a 53-week fiscal year. The outlook includes the impact of the additional week.

For fiscal 2020, the company projects net earnings from continuing operations in a range of $6.30 to $6.45 per share. This includes about $0.15 related to the additional 53rd week.

Total sales growth for the year is now forecast in the range of 5.3 to 6.3 percent, including about 2 percent growth related to the 53rd week. Same-restaurant sales growth for the year is expected in a range of 1.0 to 2.0 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $6.46 per share on sales growth of 7.0 percent to $9.13 billion for the year. Analysts' estimates typically exclude special items.

Darden's Board of Directors also declared a 17 percent higher regular quarterly cash of $0.88 on the Company's outstanding common stock, payable on August 1, 2019 to shareholders of record on July 10, 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT